A concise panel of biomarkers identifies neurocognitive functioning changes in HIV-infected individuals.
about
HIV-associated neurocognitive disorder--pathogenesis and prospects for treatmentEvidence of the innate antiviral and neuroprotective properties of progranulin.Changes in PINCH levels in the CSF of HIV+ individuals correlate with hpTau and CD4 count.Cellular Interactions and Signaling in neuroAIDS: Emerging Issues ColloquiumControversies in HIV-associated neurocognitive disordersInvestigating the role of ankyrin-rich membrane spanning protein in human immunodeficiency virus type-1 Tat-induced microglia activation.Plasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy.Reduced neural specificity in middle-aged HIV+ women in the absence of behavioral deficits.The Interleukin-1 Balance During Encephalitis Is Associated With Clinical Severity, Blood-Brain Barrier Permeability, Neuroimaging Changes, and Disease Outcome.CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease.Biomarkers for NeuroAIDS: recent progress in the field.European Mitochondrial DNA Haplogroups are Associated with Cerebrospinal Fluid Biomarkers of Inflammation in HIV Infection.HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment.Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals.Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.Immune activation and neuroinflammation in alcohol use and HIV infection: evidence for shared mechanisms.Neurocognitive dysfunction in HIV-infected youth: investigating the relationship with immune activation.Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium.Alcohol use predicts elevation in inflammatory marker soluble CD14 in men living with HIV.Modifications in acute phase and complement systems predict shifts in cognitive status of HIV-infected patients.Latent Toxoplasma Infection and Higher Toxoplasma gondii Immunoglobulin G Levels Are Associated With Worse Neurocognitive Functioning in HIV-Infected Adults.Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy.CSF/plasma HIV-1 RNA discordance even at low levels is associated with up-regulation of host inflammatory mediators in CSFCerebrospinal fluid metabolomics implicate bioenergetic adaptation as a neural mechanism regulating shifts in cognitive states of HIV-infected patientsMarkers of Microbial Translocation and Immune Activation Predict Cognitive Processing Speed in Heavy-Drinking Men Living with HIV.Cognitive function among antiretroviral treatment-naïve individuals infected with HIV-1 Subtype G versus CRF02_AG in Nigeria.Aged Chinese-origin rhesus macaques infected with SIV develop marked viremia in absence of clinical disease, inflammation or cognitive impairment.
P2860
Q26766448-B96DE1D2-7586-4BBC-9685-017110CEC029Q33690042-43BC9DA9-8ACE-4343-BED4-1DD82D734374Q33924678-6BD9AC47-1B60-401A-AF2E-24722ACB4576Q33925534-025B14FA-8332-45ED-A731-7BB11B25D78EQ35037015-75783C07-547B-4075-BB50-4BA62B7DFE78Q35220407-4952243F-E91B-4E08-819F-9A93C471933EQ35582240-CF0BDFA1-4EC6-4B8A-B2AD-700F0763891DQ35953242-5B7974E0-8E18-4B26-9DFE-6CE23BF4F3EEQ36816593-D2FD2F66-3F81-4DC5-804C-D888028428B4Q37226549-14A00434-C9C4-4F85-802A-77842FC64A77Q37513800-3D366802-D0EA-4C36-8B09-08E1C6A099C0Q37701959-C0B15579-3D6E-4438-8732-54F8011CEA62Q38223328-6CB6F12D-F8C5-4F54-BBCE-A20002617E2AQ38437153-765DFB8B-80BD-4CD9-97D4-82A53BB6D043Q38817668-DA0D91A2-7D94-4678-BA91-393510D82272Q38830540-06263BBF-4BD2-48B7-B772-9F2F5C38467BQ38887687-8F8BC32A-345A-41FD-A998-9291342E3A9FQ39077826-12583D9D-3E35-4835-A389-DCE858DC98A2Q39724280-9862A42C-E2A2-4116-936D-5A83868B9308Q40175740-75BB405E-C3F3-4CB8-A57A-E40F83CA2B8CQ40477270-5ED7D2E1-21AD-4054-ACB2-B73143D7782FQ40478740-493371D4-98FA-4EA5-B611-4964E73EDD41Q40692788-BDEB3323-35E0-480A-8807-9E7593838606Q41528498-530430EB-F2A3-4A13-B3C5-355B0FBBC9D7Q41995680-235400C9-C825-4A7A-8BCD-09B7D59FFF73Q46399734-20235EBD-DBAD-4128-A12F-9B5165860E23Q47547047-EF98E144-8C5A-48F5-8B19-BE6FBDAF0A19
P2860
A concise panel of biomarkers identifies neurocognitive functioning changes in HIV-infected individuals.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A concise panel of biomarkers ...... s in HIV-infected individuals.
@en
A concise panel of biomarkers ...... s in HIV-infected individuals.
@nl
type
label
A concise panel of biomarkers ...... s in HIV-infected individuals.
@en
A concise panel of biomarkers ...... s in HIV-infected individuals.
@nl
prefLabel
A concise panel of biomarkers ...... s in HIV-infected individuals.
@en
A concise panel of biomarkers ...... s in HIV-infected individuals.
@nl
P2093
P2860
P50
P1476
A concise panel of biomarkers ...... s in HIV-infected individuals.
@en
P2093
Ajay R Bharti
Debra Rosario Cookson
Donald Franklin
Reena Deutsch
Thomas D Marcotte
P2860
P2888
P304
P356
10.1007/S11481-013-9504-2
P577
2013-10-08T00:00:00Z